Save your place

Sign in to WhoBought

Please try again later.

Invesco's United Therapeutics Corporation (UTHR) position

Yes: as of Q1 2026, Invesco holds 608K shares of UTHR worth $361M (0.1% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$361M
Shares held
608K
% of portfolio
0.1%
Est. average buy price (i)
$336.31
est. since Q3 2025
Quarter-end price
$592.98

Estimated trade prices

Average price in quarters with purchases
$281.64
Average prices in quarters with sales
  • Q1 2026: $498.02 (392 shares sold)
  • Q4 2025: $465.70 (28K shares sold)
  • Q3 2024: $337.80 (43K shares sold)
  • Q2 2024: $264.67 (105K shares sold)
  • Q4 2023: $230.49 (3K shares sold)
  • Q3 2023: $230.33 (106K shares sold)
  • Q2 2023: $221.53 (15K shares sold)
  • Q1 2023: $246.53 (13K shares sold)
  • Q1 2022: $190.51 (52K shares sold)
  • Q4 2021: $196.31 (67K shares sold)
  • Q3 2021: $196.97 (217K shares sold)
  • Q2 2021: $190.45 (65K shares sold)

UTHR price vs Invesco's position

1Y 3Y 5Y MAX
Dates
$100$200$400$60020222023202420252026Sold 217K shares (38.2%) · Q3 2021. Average closing price $196.97 · Price range $179.86–$214.88217KsharessoldSold 67K shares (19.0%) · Q4 2021. Average closing price $196.31 · Price range $184.32–$216.0867KsharessoldSold 52K shares (18.3%) · Q1 2022. Average closing price $190.51 · Price range $166.16–$213.9652KsharessoldAdded 39K shares (16.9%) · Q2 2022. Average closing price $203.30 · Price range $174.81–$241.1439KsharespurchasedAdded 13K shares (4.8%) · Q3 2022. Average closing price $223.56 · Price range $203.30–$244.1713KsharespurchasedAdded 78K shares (27.5%) · Q4 2022. Average closing price $252.44 · Price range $205.95–$280.4378KsharespurchasedSold 13K shares (3.6%) · Q1 2023. Average closing price $246.53 · Price range $212.99–$276.1713KsharessoldSold 15K shares (4.4%) · Q2 2023. Average closing price $221.53 · Price range $206.86–$232.9915KsharessoldSold 106K shares (31.8%) · Q3 2023. Average closing price $230.33 · Price range $211.82–$248.24106KsharessoldSold 3K shares (1.3%) · Q4 2023. Average closing price $230.49 · Price range $214.88–$256.943KsharessoldAdded 217K shares (96.5%) · Q1 2024. Average closing price $225.66 · Price range $210.76–$249.51217KsharespurchasedSold 105K shares (23.8%) · Q2 2024. Average closing price $264.67 · Price range $228.26–$319.04105KsharessoldSold 43K shares (12.8%) · Q3 2024. Average closing price $337.80 · Price range $311.04–$363.5543KsharessoldAdded 24K shares (8.3%) · Q4 2024. Average closing price $367.56 · Price range $348.65–$410.0024KsharespurchasedAdded 147K shares (46.1%) · Q1 2025. Average closing price $342.70 · Price range $304.42–$380.78147KsharespurchasedAdded 420K shares (90.2%) · Q2 2025. Average closing price $298.86 · Price range $276.47–$328.40420KsharespurchasedSold 28K shares (4.5%) · Q4 2025. Average closing price $465.70 · Price range $415.34–$517.1328KsharessoldSold 392 shares (under 0.1%) · Q1 2026. Average closing price $498.02 · Price range $464.93–$592.98392sharessold← Earlier —1 sell
Average closing price · filing quarter
$498.02
Price range · filing quarter
$464.93 – $592.98
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −392 −$195K −0.1% 608K May 12, 2026
Q4 2025 Reduced −28K −$13M −4.5% 609K Feb 19, 2026
Q3 2025 First covered – – – 637K Nov 13, 2025
Q2 2025 Added +420K +$125M +90.2% 885K Aug 13, 2025
Q1 2025 Added +147K +$50M +46.1% 465K May 12, 2025
Q4 2024 Added +24K +$9.0M +8.3% 318K Feb 13, 2025
Q3 2024 Reduced −43K −$15M −12.8% 294K Nov 12, 2024
Q2 2024 Reduced −105K −$28M −23.8% 337K Aug 13, 2024
Q1 2024 Added +217K +$49M +96.5% 443K May 14, 2024
Q4 2023 Reduced −3K −$664K −1.3% 225K Feb 13, 2024
Q3 2023 Reduced −106K −$25M −31.8% 228K Nov 13, 2023
Q2 2023 Reduced −15K −$3.4M −4.4% 335K Aug 11, 2023
Q1 2023 Reduced −13K −$3.3M −3.6% 350K May 12, 2023
Q4 2022 Added +78K +$20M +27.5% 363K Feb 13, 2023
Q3 2022 Added +13K +$2.9M +4.8% 285K Nov 14, 2022
Q2 2022 Added +39K +$8.0M +16.9% 272K Aug 15, 2022
Q1 2022 Reduced −52K −$9.9M −18.3% 233K May 16, 2022
Q4 2021 Reduced −67K −$13M −19.0% 285K Feb 14, 2022
Q3 2021 Reduced −217K −$43M −38.2% 351K Nov 15, 2021
Q2 2021 Reduced −65K −$12M −10.2% 568K Aug 17, 2021
Q1 2021 First covered – – – 633K May 17, 2021
Data through Q1 2026 · filed May 12, 2026
21 grouped rows from 21 quarters

Who else owns UTHR

Avoro Capital Advisors LLC
owns 6.2% of shares outstanding
Est. $1.6B · Shares: 2.6M

Wellington Management Group LLP
owns 5.3% of shares outstanding
Est. $1.3B · Shares: 2.3M

Renaissance Technologies LLC

 View investor →
owns 4.2% of shares outstanding
Est. $1.1B · Shares: 1.8M

Janus Henderson Group PLC
owns 2.0% of shares outstanding
Est. $514M · Shares: 867K

See all owners of UTHR →

More Invesco positions

NVIDIA Corporation(NVDA)
$24.7B
3.8% of portfolio

Apple Inc.(AAPL)
$18.4B
2.8% of portfolio

Microsoft Corporation(MSFT)
$15.7B
2.4% of portfolio

Alphabet Inc.(GOOGL)
$12.9B
2.0% of portfolio

Amazon.com, Inc.(AMZN)
$11.8B
1.8% of portfolio

Broadcom Inc.(AVGO)
$10.3B
1.6% of portfolio

Common questions

Does Invesco own UTHR?

Yes. As of Q1 2026, Invesco disclosed 608K shares of UTHR, worth $361M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Invesco buy UTHR?

Invesco held UTHR since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Invesco sell UTHR?

The quarter-by-quarter table above shows each sale and reduction Invesco disclosed in UTHR. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of UTHR does Invesco own?

Invesco disclosed 608K shares of UTHR as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Invesco pay for UTHR?

Invesco began building the UTHR position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.